Nicolini S.; Ambrosini V.; Fantini L.; Fanti S., 68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level., «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 591 - 592 [Scientific article]
Ambrosini V.; Campana D.; Tomassetti P.; Fanti S., 68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39 Suppl 1., pp. 52 - 60 [Scientific article]
Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M., A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma., «ANNALS OF ONCOLOGY», 2012, 23, pp. 415 - 420 [Scientific article]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [Scientific article]
Treglia G; Castaldi P; Villani MF; Perotti G; de Waure C; Filice A; Ambrosini V; Cremonini N; Santimaria M; Versari A; Fanti S; Giordano A; Rufini V., Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 569 - 580 [Scientific article]
Piccardo A.; Lopci E.; Conte M.; Garaventa A.; Foppiani L.; Altrinetti V.; Nanni C.; Bianchi P.; Cistaro A.; Sorrentino S.; Cabria M.; Pession A.; Puntoni M.; Villavecchia G.; Fanti S., Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 57 - 71 [Scientific article]
P. Spinnato; A. Bazzocchi; A. Brioli; C. Nanni; E. Zamagni; U. Albisinni; M. Cavo; S. Fanti; G. Battista; E. Salizzoni, Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. 4013 - 4018 [Scientific article]
Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S., Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 4 - 12 [Scientific article]
Ambrosini V.; Savelli F.; Merli E.; Zompatori M.; Nanni C.; Allegri V.; Fanti S., F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease, «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 196 - 197 [Scientific article]
C. Nanni;L. Boriani;C. Salvadori;E. Zamparini;G. Rorato;V. Ambrosini;A. Gasbarrini;F. Tumietto;F. Cristini;L. Scudeller;S. Boriani;P. Viale;S. Fanti, FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1538 - 1544 [Scientific article]
Lopci E; Zanoni L; Chiti A; Fonti C; Santi I; Zinzani P.L.; Fanti S., FDG PET/CT predictive role in follicular lymphoma., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 864 - 871 [Scientific article]
Cerci J.J.; Zanoni L.; Meneghetti J.C.; Fanti S., FDG- PET in Lymphoma: Nuclear Medicine Perspective., in: ELSTROM R.L. SCHUSTER S.J., PET imaging of Lymphoma, PHILADELPHIA, W.B. Saunders Company-Elsevier, 2012, pp. 21 - 33 [Chapter or essay]
Lopci E.; D'Ambrosio D.; Nanni C.; Chiti A.; Pession A.; Marengo M.; Fanti S., Feasibility of carbidopa premedication in pediatric patients: a pilot study., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2012, 27, pp. 729 - 733 [Scientific article]
Hartmann S; Agostinelli C; Diener J; Döring C; Fanti S; Zinzani PL; Gallamini A; Bergmann L; Pileri S; Hansmann ML., GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers., «BMC CANCER», 2012, 12, Article number: 586 , pp. 1 - 7 [Scientific article]Open Access
Ambrosini V.; Campana D.; Nanni C.; Cambioli S.; Tomassetti P.; Rubello D.; Fanti S., Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1278 - 1283 [Scientific article]
